KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Amortizatization of Intangibles: 2018-2025

Historic Amortizatization of Intangibles for Adaptive Biotechnologies (ADPT) over the last 8 years, with Sep 2025 value amounting to $428,000.

  • Adaptive Biotechnologies' Amortizatization of Intangibles changed negligibly% to $428,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 49.38%. This contributed to the annual value of $8.2 million for FY2024, which is 10.63% down from last year.
  • Latest data reveals that Adaptive Biotechnologies reported Amortizatization of Intangibles of $428,000 as of Q3 2025, which was up 1.18% from $423,000 recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Amortizatization of Intangibles high stood at $3.5 million for Q4 2022, and its period low was -$2.1 million during Q1 2021.
  • Over the past 3 years, Adaptive Biotechnologies' median Amortizatization of Intangibles value was $428,000 (recorded in 2025), while the average stood at $1.1 million.
  • Per our database at Business Quant, Adaptive Biotechnologies' Amortizatization of Intangibles tumbled by 479.14% in 2021 and then skyrocketed by 375.96% in 2022.
  • Adaptive Biotechnologies' Amortizatization of Intangibles (Quarterly) stood at -$1.3 million in 2021, then surged by 375.96% to $3.5 million in 2022, then dropped by 16.03% to $3.0 million in 2023, then tumbled by 50.73% to $1.5 million in 2024, then remained steady at $428,000 in 2025.
  • Its last three reported values are $428,000 in Q3 2025, $423,000 for Q2 2025, and $958,000 during Q1 2025.